-
Tytuł:
-
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
-
Autorzy:
-
Long H; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.
Nie L; Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.
Xiang X; Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.
Li H; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.
Zhang X; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.
Fu X; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.
Ren H; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.
Liu W; Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.
Wang Q; Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.
Wu Q; Internal Medicine of Tianyou Hospital, Wuhan University of Science and Technology, Wuhan 430064, China.; Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.
-
Źródło:
-
BioMed research international [Biomed Res Int] 2020 Jun 16; Vol. 2020, pp. 6159720. Date of Electronic Publication: 2020 Jun 16 (Print Publication: 2020).
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: New York, NY : Hindawi Pub. Co.
-
MeSH Terms:
-
Betacoronavirus*
Prothrombin Time*
Coronavirus Infections/*blood
Fibrin Fibrinogen Degradation Products/*metabolism
Pneumonia, Viral/*blood
Adult ; Aged ; Aged, 80 and over ; Blood Coagulation Disorders/etiology ; Blood Coagulation Disorders/mortality ; COVID-19 ; China/epidemiology ; Coronavirus Infections/complications ; Coronavirus Infections/mortality ; Disease Progression ; Female ; Fibrinogen/metabolism ; Humans ; Lung/diagnostic imaging ; Male ; Middle Aged ; Pandemics ; Partial Thromboplastin Time ; Pneumonia, Viral/complications ; Pneumonia, Viral/mortality ; Prognosis ; SARS-CoV-2 ; Thrombin Time ; Tomography, X-Ray Computed
-
References:
-
J Evid Based Med. 2020 Feb;13(1):3-7. (PMID: 32048815)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
J Thromb Haemost. 2020 Apr;18(4):844-847. (PMID: 32073213)
Nature. 2002 Dec 19-26;420(6917):885-91. (PMID: 12490963)
J Med Virol. 2020 May;92(5):461-463. (PMID: 32073161)
JAMA. 2020 Feb 7;:. (PMID: 32031570)
FASEB J. 2008 Aug;22(8):2880-7. (PMID: 18424768)
J Travel Med. 2020 Mar 13;27(2):. (PMID: 32052846)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Growth Factors. 2018 Aug;36(3-4):89-103. (PMID: 30318940)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):69-80. (PMID: 26450781)
Am J Physiol Lung Cell Mol Physiol. 2015 Apr 1;308(7):L650-7. (PMID: 25617378)
N Engl J Med. 2020 Apr 30;382(18):1677-1679. (PMID: 32109012)
J Virol. 2020 Mar 17;94(7):. (PMID: 31996437)
-
Substance Nomenclature:
-
0 (Fibrin Fibrinogen Degradation Products)
0 (fibrin fragment D)
9001-32-5 (Fibrinogen)
-
Entry Date(s):
-
Date Created: 20200630 Date Completed: 20200706 Latest Revision: 20220415
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7301188
-
DOI:
-
10.1155/2020/6159720
-
PMID:
-
32596339
-
Objective: To investigate the value of coagulation indicators D-dimer (DD), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (Fg) in predicting the severity and prognosis of COVID-19.
Methods: A total of 115 patients with confirmed COVID-19, who were admitted to Tianyou Hospital of Wuhan University of Science and Technology between January 18, 2020, and March 5, 2020, were included. The dynamic changes of DD, PT, APTT, and Fg were tested, and the correlation with CT imaging, clinical classifications, and prognosis was studied.
Results: Coagulation disorder occurred at the early stage of COVID-19 infection, with 50 (43.5%) patients having DD increased and 74 (64.3%) patients having Fg increased. The levels of DD and Fg were correlated with clinical classification. Among 23 patients who deceased, 18 had DD increased at the first lab test, 22 had DD increased at the second and third lab tests, and 18 had prolonged PT at the third test. The results from ROC analyses for mortality risk showed that the AUCs of DD were 0.742, 0.818, and 0.851 in three times of test, respectively; PT was 0.643, 0.824, and 0.937. In addition, with the progression of the disease, the change of CT imaging was closely related to the increase of the DD value ( P < 0.01).
Conclusions: Coagulation dysfunction is more likely to occur in severe and critically ill patients. DD and PT could be used as the significant indicators in predicting the mortality of COVID-19.
Competing Interests: All authors reported no conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
(Copyright © 2020 Hui Long et al.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
